Search

everythinglearnresearchcommunity

for

Search:↓

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Proper antifungal treatment is crucial to avoid misdiagnosis and prevent scarring alopecia.

Water-soluble wool keratin can protect human hair from damage during treatments.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Hydroxychloroquine can help treat certain types of hair loss.

Hair fibers may have a unique, non-protein sheath not previously identified.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A rare EGFR mutation in newborns leads to severe health issues and early death.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Betulin oil doesn't stop hair loss or help regrow hair in hypothyroidism.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

Baricitinib may help treat frontal fibrosing alopecia and facial papules.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Wnt signaling is vital for cell growth, development, and cancer research.

Hair growth is cyclic and influenced mainly by local factors.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The conclusion is that certain cell interactions and signals are crucial for hair growth and regeneration.